Should You Invest in NVMI Stock Following Healthy Q2 Results?

Nova Ltd. NVMI delivered a strong performance in the second quarter of 2026, supported by healthy demand for advanced semiconductor process-control solutions. The company reported record revenues and earnings, while management’s upbeat third-quarter outlook highlighted continued momentum across advanced logic and packaging applications. 

Let us delve a little deeper into the stock’s key growth drivers.

Healthy Demand Trends Augur Well

Nova reported second-quarter revenues of $255 million, up 16% year over year and 8% sequentially. The figure surpassed the Zacks Consensus Estimate by 0.9%. Non-GAAP earnings of $2.51 per share increased 14% from the year-ago quarter and beat the consensus mark of $2.41 by 4.2%. The company surpassed earnings expectations in each of the trailing four quarters.

Growth was driven by record revenues from advanced logic devices as customers continued transitioning toward Gate-All-Around (GAA) architectures and advanced nodes. Nova also posted record revenues from advanced-packaging solutions, benefiting from capacity additions across logic and memory manufacturing.

The momentum is likely to continue in the third quarter. Management expects revenues between $277 million and $287 million, implying growth of roughly 9-13% sequentially at the endpoints. Non-GAAP earnings are projected between $2.70 and $2.85 per share. The outlook suggests that investments tied to AI, high-performance computing and increasingly complex semiconductor architectures remain important demand catalysts for Nova’s metrology portfolio.

Advanced Packaging and GAA Lend Support

Nova is well-positioned to benefit from rising process complexity in semiconductor manufacturing. As chipmakers move toward GAA transistors, advanced packaging, high-bandwidth memory and more complex device structures, the need for precise dimensional, materials and chemical metrology continues to increase.

The company achieved record sales for its front-end chemical metrology solution and Sentronics dimensional metrology products used in advanced packaging. Broad-based demand, market share gains and deeper engagement with leading-edge customers also improved visibility into future opportunities.

These trends strengthen Nova’s long-term investment case. Unlike semiconductor-equipment companies that rely mainly on wafer-fabrication capacity growth, Nova also benefits from increasing metrology intensity per wafer as manufacturing complexity rises. This gives the company an additional structural growth driver even when broader industry spending is uneven.

Price Performance

Nova has gained 32.6% in the past year compared with the industry’s growth of 47.9%. It has lagged peers like FormFactor, Inc. FORM and United Microelectronics Corporation UMC. While UMC has gained 200.8%, FORM soared 248.4% over this period.

One-Year NVMI Stock Price Performance

Image Source: Zacks Investment Research

The Verdict

Nova’s second-quarter performance reinforces the strength of its underlying business. Record revenues, continued earnings beats, growing exposure to GAA and advanced packaging and a strong third-quarter outlook support the bullish case. The recent share-price correction provides a more reasonable entry point for investors willing to tolerate volatility.

Given its strong execution, expanding process-control opportunity and favorable earnings outlook, investors may consider betting on the stock for long-term growth.

Nova currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research